CoverageForm 410-K10-Q8-K13D13G13F

Anaptysbio, Inc

ANABCIK 0001370053 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 28, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback
Full filing:tone 0.0056

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Top insiders

Most active reporters at Anaptysbio, Inc

NameRolesFilings
Schmid John P.
Director
12
Fenton Dennis M
Director
9
Orwin John A
Director
9
Marquet Magda
Director
8
Ware J. Anthony
Director
8

Showing 6-10 of 19

PrevPage 2 of 4Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Anaptysbio, Inc. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#InsiderTradesWin rateAvgMedianBestWorst
1Nodelman Oleg580%+24.6%+40.4%+42.0%-2.9%
2Ecor1 Capital, LLC667%+14.2%+21.6%+42.0%-38.0%
3Lizzul Paul F.1050%+1.4%+3.2%+60.7%-49.6%
4Renton Hollings922%-27.8%-28.2%+34.3%-81.6%
5Loumeau Eric J2322%-21.9%-37.4%+57.0%-78.0%
6Mulroy Dennis1338%-11.5%-24.6%+57.0%-49.6%

All filings

142 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue